Oncology & Cancer
Researchers study tobacco use, cancer connection
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.
Oct 20, 2020
0
1
News tagged with renal cell cancer
Oncology & Cancer
Study reveals factors influencing outcomes in kidney cancer treated with immunotherapy
By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their ...
May 29, 2020
0
72
Oncology & Cancer
Study shows cancers with high levels of the SLC7A11 gene may respond to glucose transporter inhibitor treatment
New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become "addicted" to glucose could open up fresh approaches to therapy strategies for cancers with high levels ...
Mar 30, 2020
0
90
Oncology & Cancer
Clinical trial exposes deadly kidney cancer's Achilles' heel
An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target. The finding from a team of researchers ...
Feb 20, 2020
0
30
Medical research
Novel drug targets tumor growth in advanced kidney cancer
Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease.
Feb 13, 2020
0
1
Oncology & Cancer
Researchers uncover new vulnerability in kidney cancer
A UT Southwestern researcher led a team that identified a new vulnerability in kidney tumors, the 10th most common cause of cancer death in men and women.
Jan 17, 2020
0
160
Oncology & Cancer
Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart
Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. ...
Dec 4, 2019
0
1
Medications
Favorable five-year survival reported for patients with advanced cancer treated with the immunotherapy
A research team led by experts at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center reports favorable five-year survival rates from the first multidose clinical trial of the ...
Jul 25, 2019
2
1276
Oncology & Cancer
New, revised topics released in ACR appropriateness criteria
(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 clinical variants covering ...
Apr 9, 2019
0
1
Medical research
Personalized in vitro model enables drug screening for kidney cancer
One way to treat the most common type of kidney cancer is to use anti-angiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer ...
Mar 27, 2019
0
2
